Myriad Genetics (MYGN) Insider Trading & Ownership $7.28 -0.09 (-1.15%) As of 01:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Myriad Genetics (NASDAQ:MYGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.47 M Get MYGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Myriad Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MYGN Insider Buying and Selling by Quarter Myriad Genetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/11/2024Paul J DiazCEOSell15,000$22.93$343,950.00 9/9/2024Heinrich DreismannDirectorSell10,000$27.05$270,500.00 9/3/2024Colleen F ReitanDirectorSell46,012$27.95$1,286,035.40 6/3/2024Daniel K SpiegelmanDirectorSell3,788$22.04$83,487.52 5/15/2024Paul J DiazCEOSell75,000$25.07$1,880,250.00 5/13/2024Lee Nisley NewcomerDirectorSell6,200$25.30$156,860.00 5/13/2024Paul J DiazCEOSell57,844$25.13$1,453,619.72 (Data available from 1/1/2013 forward) MYGN Insider Trading Activity - Frequently Asked Questions Who is on Myriad Genetics's Insider Roster? The list of insiders at Myriad Genetics includes Colleen F Reitan, Daniel K Spiegelman, Heinrich Dreismann, Lee Nisley Newcomer, Nicole Lambert, Paul J Diaz, and Richard Bryan Riggsbee. Learn more on insiders at MYGN. What percentage of Myriad Genetics stock is owned by insiders? 2.10% of Myriad Genetics stock is owned by insiders. Learn more on MYGN's insider holdings. Which Myriad Genetics insiders have been selling company stock? The following insiders have sold MYGN shares in the last 24 months: Colleen F Reitan ($1,286,035.40), Daniel K Spiegelman ($282,247.90), Heinrich Dreismann ($270,500.00), Lee Nisley Newcomer ($156,860.00), Paul J Diaz ($3,677,819.72), and Richard Bryan Riggsbee ($470,700.00). How much insider selling is happening at Myriad Genetics? Insiders have sold a total of 252,482 Myriad Genetics shares in the last 24 months for a total of $6,144,163.02 sold. Myriad Genetics Key ExecutivesMr. Paul J. Diaz (Age 62)CEO, President & Director Compensation: $2.31MMr. Samraat S. Raha (Age 51)Chief Operating Officer Compensation: $514.76kDr. Dale Muzzey Ph.D. (Age 44)Chief Scientific Officer Compensation: $816.5kMr. Mark S. Verratti (Age 56)Chief Commercial Officer Compensation: $915.81kMr. Scott J. Leffler (Age 49)Chief Financial Officer Ms. Natalie Munk (Age 43)Principal Accounting Officer Dr. Kevin Richard Haas Ph.D. (Age 38)Chief Technology Officer Compensation: $580.36kMr. Matthew ScaloSenior Vice President of Investor RelationsMr. Glenn FarrellSenior VP & Chief Marketing OfficerMs. Shereen Solaiman (Age 51)Chief People Officer More Insider Trading Tools from MarketBeat Related Companies FOLD Insider Trades LGND Insider Trades BCRX Insider Trades MNKD Insider Trades DVAX Insider Trades CLDX Insider Trades INVA Insider Trades NVAX Insider Trades OPK Insider Trades GERN Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:MYGN) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.